AzTrials
AzTrials

Cost AnalysisNCT07210866

An Artificial Intelligence Model for Intensive Care Length of Stay, Neurological Outcome and Costs Estimation After Cardiopulmonary Resuscitation: a Cohort Study.

An observational study of Cost Analysis and Length of ICU Stay, run by Bezmialem Vakif University.

Not yet recruiting

Opening soon. The study is approved but enrolment has not started yet. Sites may already take enquiries.

Official record
Search all trials

Trial summary

The study aims to overview patients registered to Bezmialem Vakıf University Hospital Intensive Care Unit after successive cardiac arrest resuscitation from October 2010 to September 2025. Read more about this study

Who is it for?
Ages 18 years and older
What is being tested?
no physical or medical interventions
How many people
5,000 participants
Where
No sites listed yet
Study dates
1 Oct 2025to 1 Dec 2025
Phase
Observational
Are there results?
Not yet: the study is under way

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Study population: Patients above 18 years after successful cardiopulmonary resuscitation with ROSC registered at Bezmialem Vakıf University Hospital Intensive care unit from October 2010 to September 2025 will be included in the resesarch.

Who may be able to join

  • age>18 years
  • successive cardiopulmonary resuscitation
  • at least 1 hour long admission to ICU after Return Of Spontaneous Circulation (ROSC)

Who cannot join

  • age < 18 years
  • >80% missing data in patient records
  • patients with no ROSC

About this study

Official title: AN ARTIFICIAL INTELLIGENCE MODEL FOR INTENSIVE CARE LENGTH OF STAY, NEUROLOGICAL OUTCOME AND COSTS ESTIMATION AFTER CARDIOPULMONARY RESUSCITATION: A COHORT STUDY

The study aims to overview patients registered to Bezmialem Vakıf University Hospital Intensive Care Unit after successive cardiac arrest resuscitation from October 2010 to September 2025. The goal is to determine length of stay in reanimation, neurological clinical outcome and costs of these patients at discharge from the department. All these data is intended to be evaluated by artificial intelligence to evaluate a predictive model.

Being tested
no physical or medical interventions
Keywords
machine learning, cardiopulmonary rescucitation, lenght of stay, cost analysis, neurological outcome

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • no physical or medical interventionsOther

    Data from patients after successive rescucitaion will be evaluated by machine learning programs.

Study groups in NCT07210866
Study groupRoleWhat they receive
Age >18 years patients after successful cardiopulmonary resuscitation observed in reanimationNot described
Receives: Other: no physical or medical interventions

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Machine Learning Python programme

    The created database will be analyzed using a machine learning artificial intelligence algorithm with the Python programming language. After processing missing and incomplete data by artificial intelligence, the database will be divided into two parts: model training and model validation. Meaningful data will be selected through model training, and a prediction model will be built based on these data. To increase the interpretability of the prediction model and help users understand how and why certain predictions are made, the SHapley Additive exPlanations (SHAP) algorithm will be used. In machine learning, the SHAP technique is used to interpret the decision-making processes of complex machine learning models.

    Measured: 3 months

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted7 Oct 2025
  2. Study start1 Oct 2025 (estimated)
  3. Primary completion1 Dec 2025 (estimated)
  4. Study completion1 Dec 2025 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Observational
Observational model
Cohort
Time perspective
Retrospective
Enrolment
5,000 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT07210866
Sponsor's protocol ID
Nkangarli002
Status last verified
Sep 2025
First submitted
30 Sep 2025
Last updated
7 Oct 2025
Results posted
No
FDA-regulated drug
No
FDA-regulated device
No

Questions about this trial

What is this clinical trial studying?

An observational study of Cost Analysis and Length of ICU Stay, run by Bezmialem Vakif University.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 3 inclusion and 3 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: opening soon, as of the sponsor's last update on 7 Oct 2025. Status can change between updates, so confirm with the study contact before making plans.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

This study is still under way. Results are not available in the source record yet.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Machine Learning Python programme (time frame: 3 months). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 7 Oct 2025.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in